Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Organabio, LLC, headquartered in the United States, is a pioneering company in the biotechnology sector, specialising in innovative solutions for the life sciences industry. Founded in 2015, Organabio has rapidly established itself as a leader in organoid technology, providing unique products and services that enhance research capabilities in drug discovery and disease modelling.
With a focus on high-quality organoid models, Organabio's offerings stand out due to their precision and reproducibility, catering to researchers and pharmaceutical companies alike. The company has achieved significant milestones, including collaborations with major academic institutions and contributions to groundbreaking studies. As a trusted partner in the biotechnology field, Organabio continues to drive advancements that support the evolving needs of the scientific community.
-19 vs industry average
Organabio, LLC’s score of 13 is lower than 8% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medical Device Manufacturing has below-average carbon intensity
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
No reported emissions data is available for Organabio, LLC yet.
Organabio, LLC, headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Organabio may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives at this time. As such, the company appears to be in the early stages of addressing its climate impact, with no inherited emissions data from a parent organisation or corporate family.
No climate goals have been disclosed for Organabio, LLC yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more